Company news
Sedana Medical Ab (OMXSTO:SEDANA) news
Sedana Medical Ab news releases on 6ix. Latest, Aug 31, 2026: Sedana Medical announces PDUFA target action date for its New Drug Application in the U.S.
Press releases & updates
Sedana Medical announces PDUFA target action date for its New Drug Application in the U.S.
August 31, 2026
Sedana Medical announces FDA acceptance for review of its New Drug Application in the U.S.
August 19, 2026
Sedana Medical : Interim report January-June 2026
July 17, 2026
Sedana Medical submits New Drug Application to the U.S. FDA for inhaled sedation in the ICU
June 17, 2026
Sedana Medical publishes its Annual Report for 2025
April 14, 2026
Sedana Medical reports first patient treated in Early Access Program in the U.S.
March 13, 2026
Sedana Medical appoints Mikael Haag as Chief Financial Officer (CFO)
January 27, 2026
CFO Johan Spetz to leave Sedana Medical
December 19, 2025
Sedana Medical reports positive pre-NDA meeting with FDA
November 24, 2025